According to a new report published by Allied Market Research, titled, “drug screening laboratory services market by services type, sample type, and end user: Opportunity Analysis and Industry Forecast, 2019-2027,”
The global drug screening laboratory services market size was valued at $6,720.4 million in 2019, and is projected to reach $7,050.9 million by 2027, registering a CAGR of 9.4% from 2020 to 2027.
Drug screening is a technique used to determine an individual’s scope and degree of drug abuse/alcohol consumption. The tests normally screen for drugs such as marijuana, cocaine, amphetamines, benzodiazepines, PCP, and opioids (narcotics). The drug screening technique is applied in hospitals, pain management centers, drug testing centers, workplaces, and enforcement agencies.
The drug screening laboratory services market is expected to experience significant growth during the forecast period, owing to increase in alcohol consumption and use of illicit/prescribed drugs by ageing population, over use of prescribed drugs, enforcement of stringent laws mandating drug & alcohol testing, and increase in adoption of new methods & devices for drug screening. In addition, rise in regulatory approvals, product launches & services, and presence of government funding in major markets are expected to further drive growth of the global drug screening laboratory services market. However, possible manipulation of drug screening tests, and poor demand in under developed countries are expected to hinder growth of the market.
As per the industry experts, long term effect of COVID-19 outbreak is expected to be witnessed over the coming years. The outbreak has led to a situation of financial crisis in many countries. Many people lost their jobs during the pandemic. All these factors are anticipated to impact the drug screening laboratory services market in the coming years. Further, industries such as transport, oil & gas, staffing among others are facing huge loss in this pandemic which is directly impacting the drug screening market worldwide
On the basis of service type, the market is categorized into workplace drug testing and clinical toxicology. Workplace dominated the global market in 2019, and is anticipated to continue this trend during the forecast period. The key factors that drive the drug screening laboratory services market growth include increase in use of drugs and alcohol consumption by employees, which compels organizations to carry out regular drug tests, which act as a major market driver.
By sample type, the market is classified into urine sample, oral fluid sample, hair sample, and others. The urine sample segment accounts for majority of the market share in 2019, owing to rise in adoption of point of care drug screening, rapid & easy drug screening, and to detect multiple drug abuses in one test. The hair sample segment is expected to be the fastest growing segment from 2020 to 2027, owing to benefits such as non-invasive nature, low risk of sample tampering, and shorter detection window.
North America accounted for majority of the market share of the global drug screening laboratory services market in 2019, and is expected to remain dominant throughout the forecast period. This was attributed to rise in use of alcohol and illicit drugs at workplace, higher adoption of drug screening products, rise in government funding for drug testing, and increase in demand for new drug testing technologies such as fuel cell breath analyzers. On the other side, Europe is expected to experience highest growth rate during the forecast period, majorly owing to increase in prevalent incidences of drug abuse & drug addiction, rise
in healthcare reforms, and technological advancements in the field of healthcare.
The report provides a Some of the key players operating in the market include Abbott Laboratories (Alere Inc.), Quest Diagnostics Incorporated., Clinical Reference Laboratory, Inc, Laboratory Corporation Of America Holdings, Sterling Healthcare Opco, LLC/Cordant Health Solutions, ACM Global Laboratories, Inc., Omega Laboratories, Psychemedics, Millennium Health, Mayo Foundation For Medical Education and Research, and Precision Diagnostics.
Key Findings Of The Study
- By service type, the workplace drug testing segment dominated the market in 2019, and is anticipated to maintain its dominance throughout the forecast period.
- On the basis of sample type, the urine sample segment held the largest drug screening laboratory services market share in 2019, and is expected to remain dominant throughout the forecast period.
- On the basis end user, the retail segment exhibits fastest growth and is expected to grow at a CAGR of 13.1% from 2020 to 2027.
- Region wise, North America is expected to experience growth at the highest rate, registering a CAGR of 11.3% during the forecast period.